It is with great sadness, we report the death of Professor Alan Jardine who died on 3^rd April 2025 after a long illness. He was 64 years old.

Alan graduated from the University of Glasgow in with a BSc in Physiology (1^st class, 1981) and MB ChB (commendation, 1984). He was an MRC fellow in the Glasgow Blood Pressure Unit and awarded his MD in 1991. He was subsequently appointed Senior Lecturer, then Reader and Professor of Renal Medicine at the University of Glasgow.  He served as Head of the Medical School 2010-2016.

His leadership led to a renaissance in undergraduate medical education at the University of Glasgow, imparting, a deep sense of the importance of the student experience and a commitment to intellectual and scientific rigour.

He was a deeply respected clinician and academic nephologist. He pioneered research into the excess cardiovascular risk associated with all stages of chronic kidney disease and led a number of international clinical trials, notably the ALERT and AURORA trials, addressing cardiovascular risk in kidney transplant and dialysis patients respectively. He served on numerous grant committees, editorial boards, clinical guideline committees, external examining panels and clinical trial steering committees. He published more than 250 peer-reviewed papers and authored numerous book chapters.  His engaging style made him a highly sought after invited speaker at international scientific meetings.

He trained numerous students and clinical colleagues, many of whom are now consultant nephrologists across the globe. Under his mentorship, several of his fellows were awarded prestigious research fellowships from the British Heart Foundation and Kidney Research UK and prizes such as the European Renal Association Young Investigator award. He loved clinical work and building relationships with patients at multiple clinics across Glasgow and beyond.

After his time in Glasgow, he went on to work in Australia, then Oban before returning to Glasgow Royal Infirmary. After being diagnosed with cancer in 2020, he continued seeing large numbers of patients and working on clinical trials.

In addition to his multiple clinical and academic achievements, his was renowned for his humour, kindness, sense of fun and legendary house parties. His legacy will be the numerous doctors and scientists he inspired. Alan will be deeply missed by his countless friends and colleagues in nephrology and transplant medicine globally.

Paddy Mark, Colin Geddes, Kate Stevens